Absent tumor-suppressors allow melanoma to thwart immunotherapy – Science Daily
|
Absent tumor-suppressors allow melanoma to thwart immunotherapy
Science Daily "That's evidence that anti-CTLA4 in some cases primes T cells for the next step, anti-PD1 immunotherapy. It's well known that if you don't have T cells in the tumor, anti-PD1 won't do anything, it doesn't bring T cells into the tumor," Futreal says … |
